Description
Cryopreserved is a type of cellular therapy currently being studied in clinical trials for various cancers, including colorectal cancer. It involves using cells collected from the patient's own body (autologous) after they have been processed and stored (cryopreserved). The specific details about how this therapy works and its effectiveness are still under investigation in early-phase clinical trials. These trials aim to determine the safety, feasibility, and potential benefits of this approach in patients with advanced solid tumors, including colorectal cancer, often in combination with other therapies like N-803. The trials often involve collecting cells before standard treatment and then administering the processed cells later, sometimes alongside other agents.
Mechanism of Action
Cryopreserved is an autologous cellular therapy. This means cells are collected from the patient, processed, and then given back to the patient. The specific type of cells used and how they are processed are being investigated. The goal is likely to harness the patient's own immune system or other cellular components to fight the cancer. The exact mechanism of action is still being studied in clinical trials.
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.